NCT05033288
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for Management of Pelvic Sarcomas Involving the Bone No drug interventions Not Available Not Available recruiting NCT04845893
Observational Study on Skeletal Ewing's Sarcoma No drug interventions Not Available Not Available recruiting NCT03968471
Chemotherapy-induced Necrosis in Ewing Sarcoma No drug interventions Not Available Not Available completed NCT05395741
Regorafenib in Patients With Refractory Primary Bone Tumors treatment 1 / 2 recruiting NCT00516295
Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma treatment 2 completed NCT01825902
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma diagnostic 0 completed NCT05024253
Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements. treatment 3 completed NCT00674193
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer No drug interventions Not Available Not Available completed NCT05116800
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma treatment 2 withdrawn NCT06068075
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD No drug interventions diagnostic Not Available recruiting NCT00618813
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors treatment Not Available completed NCT01795430
Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma treatment Not Available withdrawn NCT02727387
Protocol for the Treatment of Metastatic Ewing Sarcoma treatment 2 completed NCT01962103
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors treatment 1 / 2 completed NCT02389244
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas treatment 2 recruiting NCT05440786
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma treatment 2 recruiting NCT05734066
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma treatment 1 / 2 recruiting NCT06566092
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants treatment 1 recruiting NCT04890093
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors treatment 1 / 2 not_yet_recruiting NCT02867592
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors treatment 2 active_not_recruiting NCT04995003
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma treatment 1 recruiting NCT06625190
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors treatment 1 / 2 not_yet_recruiting NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) treatment 1 / 2 recruiting NCT06465199
Difluoromethylornithine (DFMO) and AMXT-1501 for Neuroblastoma, CNS Tumors, and Sarcomas treatment 1 / 2 not_yet_recruiting NCT05918640
Lurbinectedin in FET-Fused Tumors treatment 1 / 2 recruiting NCT06029218
Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy No drug interventions treatment Not Available recruiting NCT00617890
A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720) treatment 2 terminated NCT05182164
Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas treatment 2 recruiting NCT03495921
A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide treatment 3 terminated NCT05302921
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors treatment 2 active_not_recruiting NCT06451302
Risk Stratification Oriented Treatment of Pediatric Ewing Sarcoma: a Prospective Multicenter Cohort Study treatment Not Available active_not_recruiting NCT01286987
Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors treatment 1 completed NCT04337177
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors treatment 1 recruiting NCT04956198
Drug Sensitivity and Mutation Profiling No drug interventions Not Available Not Available completed NCT02536183
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors treatment 1 terminated NCT02520128
A Study of IMRT in Primary Bone and Soft Tissue Sarcoma No drug interventions treatment Not Available completed NCT02624388
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) supportive_care 2 terminated NCT06243588
Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma No drug interventions Not Available Not Available recruiting NCT00001209
A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors treatment 1 completed NCT06387485
A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning No drug interventions treatment Not Available recruiting NCT04067115
SARC037: A Phase I/II Study to Evaluate the Safety of Trabectedin in Combination With Irinotecan in Ewing Sarcoma Patients treatment 1 / 2 active_not_recruiting NCT01661400
Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors treatment 1 completed NCT02945800
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma treatment 2 active_not_recruiting NCT01610570
Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma treatment 1 / 2 terminated NCT01969942
A Phase I Study to Examine the Toxicity of Allogeneic Stem Cell Transplantation for Relapsed or Therapy Refractory Ewing Sarcoma treatment 1 withdrawn NCT02076906
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04730349
A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer treatment 1 / 2 terminated NCT00520936
A Study of Pemetrexed in Children With Recurrent Cancer treatment 2 completed NCT02013336
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors treatment 1 unknown_status NCT02982941
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors treatment 1 completed NCT00743496
A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma No drug interventions treatment 1 completed NCT03778996
SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma treatment 2 active_not_recruiting NCT05328258
Use of GnRHa During Chemotherapy for Fertility Protection treatment 3 recruiting NCT02856048
Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer treatment 2 / 3 unknown_status NCT00464620
Trial of Dasatinib in Advanced Sarcomas treatment 2 completed NCT04055220
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas treatment Not Available recruiting NCT02044120
ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma treatment 1 completed NCT01882231
Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma No drug interventions diagnostic Not Available terminated NCT00931931
HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors No drug interventions treatment 1 completed NCT03441360
Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) treatment 2 completed NCT00474760
Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors treatment 1 completed NCT02100891
Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors treatment 2 completed NCT03478462
Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma treatment 1 active_not_recruiting NCT03709680
Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors treatment 1 / 2 active_not_recruiting NCT06340204
Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma treatment 1 recruiting NCT06564272
A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma No drug interventions treatment 2 recruiting NCT05968768
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) treatment 2 recruiting NCT01807468
Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors No drug interventions treatment 2 unknown_status NCT01492569
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting No drug interventions supportive_care Not Available withdrawn NCT06156410
Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma treatment 1 recruiting NCT03029481
Single Patient Expanded Access to Ganitumab for Metastatic Ewing Sarcoma Not Available Not Available no_longer_available NCT05046314
A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma treatment 2 recruiting NCT00898755
Collecting and Storing Tissue From Young Patients With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03245450
Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors treatment 1 / 2 completed NCT03880123
Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma treatment 1 withdrawn NCT02508038
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors treatment 1 recruiting NCT04433221
Combination Immunotherapy Targeting Sarcomas No drug interventions treatment 1 / 2 unknown_status NCT04897321
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) treatment 1 recruiting NCT02581384
Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors No drug interventions treatment 1 / 2 terminated NCT01780779
Osteosarcoma and Ewing Sarcoma Treatment Response Assessment With Functional MRI Imaging in Children and Young Adults No drug interventions Not Available Not Available unknown_status NCT03715933
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas treatment 1 recruiting NCT02557854
HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors treatment 1 withdrawn NCT04129151
Palbociclib + Ganitumab In Ewing Sarcoma treatment 2 terminated NCT01625351
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas treatment 1 completed NCT00840047
Methionine PET/CT Studies In Patients With Cancer diagnostic 2 recruiting NCT00638898
Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor treatment 1 active_not_recruiting NCT02657005
TK216 in Patients With Relapsed or Refractory Ewing Sarcoma treatment 1 / 2 terminated NCT03359005
Irinotecan and Temozolomide for Ewing Sarcoma treatment 2 recruiting NCT03373097
Anti-GD2 CAR T Cells in Pediatric Patients Affected by High Risk and/or Relapsed/Refractory Neuroblastoma or Other GD2-positive Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT03604783
Phase 1, First-in-human Study of Oral TP-1287 in Patients With Advanced Solid Tumors treatment 1 terminated NCT00824083
Functional and Clinical Long-Term Outcome of Ewing Sarcoma Treatment No drug interventions Not Available Not Available completed NCT03458728
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients treatment 1 / 2 terminated NCT04791228
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors treatment 2 recruiting NCT04483778
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults treatment 1 active_not_recruiting NCT05062707
Early Ageing During Therapy in AYA Cancer Patients No drug interventions Not Available Not Available recruiting NCT04758000
Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse prevention 2 recruiting NCT05779670
Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery No drug interventions Not Available Not Available recruiting NCT03600649
Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas treatment 1 active_not_recruiting NCT03275818
Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma treatment 2 completed NCT02415816
Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas No drug interventions diagnostic Not Available active_not_recruiting NCT05266196
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) treatment 1 / 2 enrolling_by_invitation NCT03220035
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) treatment 2 active_not_recruiting NCT05605522
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours No drug interventions treatment 1 recruiting NCT05093322
A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors treatment 1 / 2 completed NCT04308330
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies treatment 1 recruiting NCT05275426
A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor treatment 2 recruiting NCT03842865
Expanded Access of Vigil in Solid Tumors No drug interventions Not Available Not Available temporarily_not_available NCT03190174
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers treatment 1 / 2 completed NCT03356782
Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas No drug interventions treatment 1 / 2 unknown_status NCT02409576
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas treatment 1 / 2 unknown_status NCT00026780
Eligibility Screening for a NCI Pediatric Oncology Branch Research Study No drug interventions Not Available Not Available completed NCT04735289
Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma No drug interventions Not Available Not Available recruiting NCT00186992
Radiation Therapy to Treat Musculoskeletal Tumors No drug interventions treatment 2 active_not_recruiting NCT06094101
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) No drug interventions treatment 1 / 2 recruiting NCT01858168
Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma treatment 1 active_not_recruiting NCT05100368
The Prognostic Value of Serum Biomarkers in Ewing's Sarcoma No drug interventions Not Available Not Available completed NCT05772312
Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery No drug interventions Not Available Not Available enrolling_by_invitation NCT03618381
EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults No drug interventions treatment 1 recruiting NCT00180947
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse treatment 2 unknown_status NCT01583543
Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma treatment 2 completed NCT01336803
Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI diagnostic 2 completed NCT00001564
A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas treatment 2 completed NCT00568464
Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) treatment 2 terminated NCT01313884
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma treatment 2 terminated NCT00004853
Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy treatment 1 completed NCT00541411
Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma treatment Not Available unknown_status NCT04671693
A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. No drug interventions prevention Not Available recruiting NCT02162732
Molecular-Guided Therapy for Childhood Cancer No drug interventions treatment Not Available completed NCT00038142
Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients treatment 2 terminated NCT02890758
Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 treatment 1 completed NCT00001335
New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma treatment 2 completed NCT01331135
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors treatment 1 completed NCT01734863
Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients No drug interventions treatment 3 withdrawn NCT00563680
QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors treatment 2 completed NCT01061840
Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer No drug interventions treatment 1 completed NCT01222767
Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy treatment 2 completed NCT00428272
HGS-ETR2 to Treat Children With Solid Tumors treatment 1 terminated NCT01169584
Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients treatment 1 completed NCT01598454
Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides treatment 1 completed NCT02511132
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma treatment 2 completed NCT02689336
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors treatment 2 withdrawn NCT00987636
Study in Localized and Disseminated Ewing Sarcoma treatment 3 completed NCT00492141
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma treatment 1 / 2 completed NCT00179816
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors treatment 1 / 2 unknown_status NCT00001686
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases No drug interventions Not Available Not Available completed NCT00165139
Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas treatment 2 completed NCT02063022
Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma treatment 3 completed NCT00001566
A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas treatment 2 completed NCT03442465
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas No drug interventions Not Available Not Available recruiting NCT02736565
Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma No drug interventions treatment 1 completed NCT01241162
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma treatment 1 completed NCT02472392
Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma treatment 1 completed NCT01674101
Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy No drug interventions supportive_care Not Available completed NCT01696669
Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults No drug interventions treatment 2 completed NCT00923650
Informed Consent in Pediatric Cancer Trials No drug interventions Not Available Not Available completed NCT02390843
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors treatment 1 completed NCT01505569
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors other Not Available completed NCT00503295
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung treatment 2 completed NCT01518413
Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid Tumors treatment 1 completed NCT00560235
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors treatment 1 / 2 completed NCT01112800
Markers of Anthracycline-Related Cardiac Muscle Injury No drug interventions Not Available Not Available withdrawn NCT03496402
Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) No drug interventions other Not Available recruiting NCT03542097
Assessment of MGMT Promoter Methylation in Advanced Ewing Sarcoma Treated With Temozolomide and Irinotecan No drug interventions Not Available Not Available completed NCT03011528
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years No drug interventions treatment 2 completed NCT02159443
Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody No drug interventions Not Available Not Available completed